| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $40.5M | -26.2% |
| SG&A Expense | $14.1M | -4.7% |
| Operating Income | -$56.8M | +18.4% |
| Income Tax | $0 | — |
| Net Income | -$51.3M | +20.7% |
| EPS (Basic) | -$1.72 | +37.2% |
| EPS (Diluted) | -$1.72 | +37.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.4M | +36.5% |
| Current Assets | $86.3M | -21.9% |
| Total Assets | $92.1M | -33.6% |
| Total Liabilities | $10.2M | -27.1% |
| Stockholders' Equity | $81.8M | -34.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.3M | +7.6% |
| Investing Cash Flow | $54.6M | +226.1% |
| Financing Cash Flow | $372K | -99.6% |